FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

12056511000001102: Mirtazapine 30mg orodispersible tablets (Actavis UK Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2008. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
43678301000001114 Mirtazapine 30mg orodispersible tablets (Actavis UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
109497101000001112 Mirtazapine 30mg orodispersible tablets (Accord Healthcare Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Mirtazapine 30mg orodispersible tablets (Actavis UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Mirtazapine 30mg orodispersible tablets (Actavis UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Mirtazapine 30mg orodispersible tablets (Actavis UK Ltd) Is a Product containing precisely mirtazapine 30 milligram/1 each conventional release orodispersible tablet (clinical drug) true Inferred relationship Existential restriction modifier
Mirtazapine 30mg orodispersible tablets (Actavis UK Ltd) Has active ingredient Mirtazapine true Inferred relationship Existential restriction modifier
Mirtazapine 30mg orodispersible tablets (Actavis UK Ltd) Has manufactured dose form Conventional release oral lyophilisate false Inferred relationship Existential restriction modifier
Mirtazapine 30mg orodispersible tablets (Actavis UK Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Mirtazapine 30mg orodispersible tablets (Actavis UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Mirtazapine 30mg orodispersible tablets (Actavis UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Mirtazapine 30mg orodispersible tablets (Actavis UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Mirtazapine 30mg orodispersible tablets (Actavis UK Ltd) Has specific active ingredient Mirtazapine true Inferred relationship Existential restriction modifier
Mirtazapine 30mg orodispersible tablets (Actavis UK Ltd) Has dispensed dose form Orodispersible tablet false Inferred relationship Existential restriction modifier
Mirtazapine 30mg orodispersible tablets (Actavis UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Mirtazapine 30mg orodispersible tablets (Actavis UK Ltd) Has dispensed dose form Conventional release orodispersible tablet true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Mirtazapine 30mg orodispersible tablets (Actavis UK Ltd) 30 tablet 5 x 6 tablets Is pack of False Mirtazapine 30mg orodispersible tablets (Actavis UK Ltd) Inferred relationship Existential restriction modifier
Mirtazapine 30mg orodispersible tablets (Actavis UK Ltd) 30 tablet 5 x 6 tablets Has AMP True Mirtazapine 30mg orodispersible tablets (Actavis UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start